nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Doxorubicin—kidney cancer	0.31	1	CbGbCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—TPX2—kidney cancer	0.00353	0.164	CbGpPWpGaD
Moxifloxacin—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.0029	0.227	CbGdCrCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HLTF—kidney cancer	0.00227	0.106	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FOSL2—kidney cancer	0.00214	0.0993	CbGpPWpGaD
Moxifloxacin—TOP2A—Vindesine—Vincristine—kidney cancer	0.00148	0.115	CbGdCrCtD
Moxifloxacin—TOP2A—Vindesine—Vinblastine—kidney cancer	0.00148	0.115	CbGdCrCtD
Moxifloxacin—TOP2A—Gefitinib—Erlotinib—kidney cancer	0.00139	0.109	CbGdCrCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—AURKA—kidney cancer	0.00119	0.0555	CbGpPWpGaD
Moxifloxacin—TOP2A—Vinorelbine—Vincristine—kidney cancer	0.000932	0.0728	CbGdCrCtD
Moxifloxacin—TOP2A—Vinorelbine—Vinblastine—kidney cancer	0.000932	0.0728	CbGdCrCtD
Moxifloxacin—TOP2A—Vincristine—Vinblastine—kidney cancer	0.000797	0.0623	CbGdCrCtD
Moxifloxacin—Norfloxacin—CYP1A1—kidney cancer	0.00068	0.311	CrCbGaD
Moxifloxacin—TOP2A—Vinblastine—Vincristine—kidney cancer	0.000641	0.0501	CbGdCrCtD
Moxifloxacin—Sparfloxacin—ABCB1—kidney cancer	0.000633	0.289	CrCbGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—APC—kidney cancer	0.000632	0.0294	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—kidney cancer	0.000615	0.0286	CbGpPWpGaD
Moxifloxacin—TOP2A—Cytarabine—Gemcitabine—kidney cancer	0.000524	0.0409	CbGdCrCtD
Moxifloxacin—TOP2A—Epirubicin—Doxorubicin—kidney cancer	0.000449	0.0351	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	0.000449	0.0351	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Doxorubicin—kidney cancer	0.000449	0.0351	CbGdCrCtD
Moxifloxacin—Levofloxacin—ABCB1—kidney cancer	0.000445	0.204	CrCbGaD
Moxifloxacin—Ciprofloxacin—ABCB1—kidney cancer	0.00043	0.197	CrCbGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—kidney cancer	0.000407	0.0189	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—SYNE2—kidney cancer	0.000398	0.0185	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—HNF1B—kidney cancer	0.000394	0.0183	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—KCNMA1—kidney cancer	0.000384	0.0178	CbGpPWpGaD
Moxifloxacin—TOP2A—Azacitidine—Gemcitabine—kidney cancer	0.000375	0.0293	CbGdCrCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—PSMD7—kidney cancer	0.000359	0.0167	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000359	0.0167	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000359	0.0167	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—kidney cancer	0.000349	0.0162	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—JUND—kidney cancer	0.000344	0.016	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.00034	0.0158	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—MYC—kidney cancer	0.00033	0.0153	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000296	0.0137	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000272	0.0126	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—TP53—kidney cancer	0.000271	0.0126	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—kidney cancer	0.000262	0.0122	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000244	0.0113	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000244	0.0113	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000228	0.0106	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—EGR1—kidney cancer	0.000219	0.0102	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	0.000206	0.00957	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.0002	0.00931	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000199	0.00923	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000194	0.00902	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	0.000189	0.00877	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	0.00018	0.00836	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	0.00015	0.00697	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	0.000144	0.00671	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.00014	0.0065	CbGpPWpGaD
Moxifloxacin—Dysgeusia—Capecitabine—kidney cancer	0.000134	0.000205	CcSEcCtD
Moxifloxacin—Dizziness—Sunitinib—kidney cancer	0.000134	0.000205	CcSEcCtD
Moxifloxacin—Feeling abnormal—Gemcitabine—kidney cancer	0.000134	0.000205	CcSEcCtD
Moxifloxacin—Shock—Paclitaxel—kidney cancer	0.000134	0.000205	CcSEcCtD
Moxifloxacin—Vomiting—Sorafenib—kidney cancer	0.000134	0.000205	CcSEcCtD
Moxifloxacin—Abdominal pain upper—Doxorubicin—kidney cancer	0.000134	0.000204	CcSEcCtD
Moxifloxacin—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000134	0.000204	CcSEcCtD
Moxifloxacin—Nervous system disorder—Paclitaxel—kidney cancer	0.000133	0.000204	CcSEcCtD
Moxifloxacin—Hypokalaemia—Doxorubicin—kidney cancer	0.000133	0.000204	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000133	0.000204	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	0.000133	0.00617	CbGpPWpGaD
Moxifloxacin—Tachycardia—Paclitaxel—kidney cancer	0.000133	0.000203	CcSEcCtD
Moxifloxacin—Rash—Sorafenib—kidney cancer	0.000133	0.000203	CcSEcCtD
Moxifloxacin—Dermatitis—Sorafenib—kidney cancer	0.000132	0.000203	CcSEcCtD
Moxifloxacin—Back pain—Capecitabine—kidney cancer	0.000132	0.000202	CcSEcCtD
Moxifloxacin—Breast disorder—Doxorubicin—kidney cancer	0.000132	0.000202	CcSEcCtD
Moxifloxacin—Skin disorder—Paclitaxel—kidney cancer	0.000132	0.000202	CcSEcCtD
Moxifloxacin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000132	0.000202	CcSEcCtD
Moxifloxacin—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000132	0.000202	CcSEcCtD
Moxifloxacin—Headache—Sorafenib—kidney cancer	0.000132	0.000202	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PSMD7—kidney cancer	0.000132	0.00611	CbGpPWpGaD
Moxifloxacin—Muscle spasms—Capecitabine—kidney cancer	0.000131	0.000201	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000131	0.000201	CcSEcCtD
Moxifloxacin—Diarrhoea—Dactinomycin—kidney cancer	0.000131	0.000201	CcSEcCtD
Moxifloxacin—Anorexia—Paclitaxel—kidney cancer	0.00013	0.000198	CcSEcCtD
Moxifloxacin—Gastritis—Doxorubicin—kidney cancer	0.000129	0.000198	CcSEcCtD
Moxifloxacin—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000129	0.000197	CcSEcCtD
Moxifloxacin—Muscular weakness—Doxorubicin—kidney cancer	0.000129	0.000197	CcSEcCtD
Moxifloxacin—Vision blurred—Capecitabine—kidney cancer	0.000129	0.000197	CcSEcCtD
Moxifloxacin—Vomiting—Sunitinib—kidney cancer	0.000129	0.000197	CcSEcCtD
Moxifloxacin—Body temperature increased—Gemcitabine—kidney cancer	0.000128	0.000196	CcSEcCtD
Moxifloxacin—Tremor—Capecitabine—kidney cancer	0.000128	0.000196	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—AURKA—kidney cancer	0.000128	0.00595	CbGpPWpGaD
Moxifloxacin—Rash—Sunitinib—kidney cancer	0.000128	0.000195	CcSEcCtD
Moxifloxacin—Dermatitis—Sunitinib—kidney cancer	0.000127	0.000195	CcSEcCtD
Moxifloxacin—Abdominal distension—Doxorubicin—kidney cancer	0.000127	0.000195	CcSEcCtD
Moxifloxacin—Hypotension—Paclitaxel—kidney cancer	0.000127	0.000194	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Capecitabine—kidney cancer	0.000127	0.000194	CcSEcCtD
Moxifloxacin—Headache—Sunitinib—kidney cancer	0.000127	0.000194	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—kidney cancer	0.000127	0.00588	CbGpPWpGaD
Moxifloxacin—Dysphagia—Doxorubicin—kidney cancer	0.000126	0.000194	CcSEcCtD
Moxifloxacin—Asthma—Doxorubicin—kidney cancer	0.000126	0.000194	CcSEcCtD
Moxifloxacin—Anaemia—Capecitabine—kidney cancer	0.000126	0.000193	CcSEcCtD
Moxifloxacin—Hypersensitivity—Vincristine—kidney cancer	0.000126	0.000193	CcSEcCtD
Moxifloxacin—Eosinophilia—Doxorubicin—kidney cancer	0.000125	0.000192	CcSEcCtD
Moxifloxacin—Nausea—Sorafenib—kidney cancer	0.000125	0.000191	CcSEcCtD
Moxifloxacin—Pancreatitis—Doxorubicin—kidney cancer	0.000124	0.00019	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000124	0.00019	CcSEcCtD
Moxifloxacin—Malaise—Capecitabine—kidney cancer	0.000123	0.000189	CcSEcCtD
Moxifloxacin—Angina pectoris—Doxorubicin—kidney cancer	0.000123	0.000188	CcSEcCtD
Moxifloxacin—Insomnia—Paclitaxel—kidney cancer	0.000123	0.000188	CcSEcCtD
Moxifloxacin—Vertigo—Capecitabine—kidney cancer	0.000123	0.000188	CcSEcCtD
Moxifloxacin—Asthenia—Vincristine—kidney cancer	0.000123	0.000188	CcSEcCtD
Moxifloxacin—Syncope—Capecitabine—kidney cancer	0.000123	0.000188	CcSEcCtD
Moxifloxacin—Leukopenia—Capecitabine—kidney cancer	0.000122	0.000187	CcSEcCtD
Moxifloxacin—Paraesthesia—Paclitaxel—kidney cancer	0.000122	0.000187	CcSEcCtD
Moxifloxacin—Vomiting—Dactinomycin—kidney cancer	0.000122	0.000186	CcSEcCtD
Moxifloxacin—Dyspnoea—Paclitaxel—kidney cancer	0.000121	0.000185	CcSEcCtD
Moxifloxacin—Somnolence—Paclitaxel—kidney cancer	0.000121	0.000185	CcSEcCtD
Moxifloxacin—Palpitations—Capecitabine—kidney cancer	0.000121	0.000185	CcSEcCtD
Moxifloxacin—Rash—Dactinomycin—kidney cancer	0.000121	0.000185	CcSEcCtD
Moxifloxacin—Nausea—Sunitinib—kidney cancer	0.00012	0.000184	CcSEcCtD
Moxifloxacin—Loss of consciousness—Capecitabine—kidney cancer	0.00012	0.000184	CcSEcCtD
Moxifloxacin—Pancytopenia—Doxorubicin—kidney cancer	0.00012	0.000184	CcSEcCtD
Moxifloxacin—Dyspepsia—Paclitaxel—kidney cancer	0.00012	0.000183	CcSEcCtD
Moxifloxacin—Cough—Capecitabine—kidney cancer	0.000119	0.000183	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	0.000119	0.00551	CbGpPWpGaD
Moxifloxacin—Dysuria—Doxorubicin—kidney cancer	0.000118	0.000181	CcSEcCtD
Moxifloxacin—Neutropenia—Doxorubicin—kidney cancer	0.000118	0.000181	CcSEcCtD
Moxifloxacin—Decreased appetite—Paclitaxel—kidney cancer	0.000118	0.000181	CcSEcCtD
Moxifloxacin—Hypertension—Capecitabine—kidney cancer	0.000118	0.000181	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—PSMD7—kidney cancer	0.000118	0.00547	CbGpPWpGaD
Moxifloxacin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000117	0.00018	CcSEcCtD
Moxifloxacin—Fatigue—Paclitaxel—kidney cancer	0.000117	0.000179	CcSEcCtD
Moxifloxacin—Diarrhoea—Vincristine—kidney cancer	0.000117	0.000179	CcSEcCtD
Moxifloxacin—Pollakiuria—Doxorubicin—kidney cancer	0.000117	0.000179	CcSEcCtD
Moxifloxacin—Asthenia—Gemcitabine—kidney cancer	0.000116	0.000178	CcSEcCtD
Moxifloxacin—Chest pain—Capecitabine—kidney cancer	0.000116	0.000178	CcSEcCtD
Moxifloxacin—Myalgia—Capecitabine—kidney cancer	0.000116	0.000178	CcSEcCtD
Moxifloxacin—Arthralgia—Capecitabine—kidney cancer	0.000116	0.000178	CcSEcCtD
Moxifloxacin—Constipation—Paclitaxel—kidney cancer	0.000116	0.000178	CcSEcCtD
Moxifloxacin—Pain—Paclitaxel—kidney cancer	0.000116	0.000178	CcSEcCtD
Moxifloxacin—Anxiety—Capecitabine—kidney cancer	0.000116	0.000177	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000116	0.000177	CcSEcCtD
Moxifloxacin—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000115	0.000177	CcSEcCtD
Moxifloxacin—Weight increased—Doxorubicin—kidney cancer	0.000115	0.000176	CcSEcCtD
Moxifloxacin—Discomfort—Capecitabine—kidney cancer	0.000115	0.000176	CcSEcCtD
Moxifloxacin—Pruritus—Gemcitabine—kidney cancer	0.000115	0.000176	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—AURKA—kidney cancer	0.000114	0.00532	CbGpPWpGaD
Moxifloxacin—Hyperglycaemia—Doxorubicin—kidney cancer	0.000114	0.000175	CcSEcCtD
Moxifloxacin—Dry mouth—Capecitabine—kidney cancer	0.000114	0.000174	CcSEcCtD
Moxifloxacin—Nausea—Dactinomycin—kidney cancer	0.000114	0.000174	CcSEcCtD
Moxifloxacin—Pneumonia—Doxorubicin—kidney cancer	0.000113	0.000174	CcSEcCtD
Moxifloxacin—Dizziness—Vincristine—kidney cancer	0.000113	0.000173	CcSEcCtD
Moxifloxacin—Infestation NOS—Doxorubicin—kidney cancer	0.000113	0.000173	CcSEcCtD
Moxifloxacin—Infestation—Doxorubicin—kidney cancer	0.000113	0.000173	CcSEcCtD
Moxifloxacin—Confusional state—Capecitabine—kidney cancer	0.000112	0.000172	CcSEcCtD
Moxifloxacin—Feeling abnormal—Paclitaxel—kidney cancer	0.000112	0.000171	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000112	0.000171	CcSEcCtD
Moxifloxacin—Oedema—Capecitabine—kidney cancer	0.000112	0.000171	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000111	0.00017	CcSEcCtD
Moxifloxacin—Diarrhoea—Gemcitabine—kidney cancer	0.000111	0.00017	CcSEcCtD
Moxifloxacin—Renal failure—Doxorubicin—kidney cancer	0.000111	0.00017	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000111	0.000169	CcSEcCtD
Moxifloxacin—Jaundice—Doxorubicin—kidney cancer	0.00011	0.000168	CcSEcCtD
Moxifloxacin—Stomatitis—Doxorubicin—kidney cancer	0.00011	0.000168	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.00011	0.0051	CbGpPWpGaD
Moxifloxacin—Shock—Capecitabine—kidney cancer	0.00011	0.000168	CcSEcCtD
Moxifloxacin—Urinary tract infection—Doxorubicin—kidney cancer	0.00011	0.000168	CcSEcCtD
Moxifloxacin—Conjunctivitis—Doxorubicin—kidney cancer	0.00011	0.000168	CcSEcCtD
Moxifloxacin—Nervous system disorder—Capecitabine—kidney cancer	0.000109	0.000167	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Capecitabine—kidney cancer	0.000109	0.000167	CcSEcCtD
Moxifloxacin—Tachycardia—Capecitabine—kidney cancer	0.000109	0.000167	CcSEcCtD
Moxifloxacin—Vomiting—Vincristine—kidney cancer	0.000109	0.000167	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000109	0.00505	CbGpPWpGaD
Moxifloxacin—Skin disorder—Capecitabine—kidney cancer	0.000108	0.000166	CcSEcCtD
Moxifloxacin—Sweating—Doxorubicin—kidney cancer	0.000108	0.000165	CcSEcCtD
Moxifloxacin—Urticaria—Paclitaxel—kidney cancer	0.000108	0.000165	CcSEcCtD
Moxifloxacin—Rash—Vincristine—kidney cancer	0.000108	0.000165	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Capecitabine—kidney cancer	0.000108	0.000165	CcSEcCtD
Moxifloxacin—Dermatitis—Vincristine—kidney cancer	0.000108	0.000165	CcSEcCtD
Moxifloxacin—Haematuria—Doxorubicin—kidney cancer	0.000108	0.000165	CcSEcCtD
Moxifloxacin—Abdominal pain—Paclitaxel—kidney cancer	0.000107	0.000164	CcSEcCtD
Moxifloxacin—Body temperature increased—Paclitaxel—kidney cancer	0.000107	0.000164	CcSEcCtD
Moxifloxacin—Headache—Vincristine—kidney cancer	0.000107	0.000164	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000107	0.000163	CcSEcCtD
Moxifloxacin—Epistaxis—Doxorubicin—kidney cancer	0.000106	0.000163	CcSEcCtD
Moxifloxacin—Anorexia—Capecitabine—kidney cancer	0.000106	0.000163	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000106	0.00493	CbGpPWpGaD
Moxifloxacin—Sinusitis—Doxorubicin—kidney cancer	0.000106	0.000162	CcSEcCtD
Moxifloxacin—Agranulocytosis—Doxorubicin—kidney cancer	0.000105	0.000161	CcSEcCtD
Moxifloxacin—Hypotension—Capecitabine—kidney cancer	0.000104	0.00016	CcSEcCtD
Moxifloxacin—Vomiting—Gemcitabine—kidney cancer	0.000103	0.000158	CcSEcCtD
Moxifloxacin—Bradycardia—Doxorubicin—kidney cancer	0.000103	0.000158	CcSEcCtD
Moxifloxacin—Rash—Gemcitabine—kidney cancer	0.000102	0.000157	CcSEcCtD
Moxifloxacin—Dermatitis—Gemcitabine—kidney cancer	0.000102	0.000157	CcSEcCtD
Moxifloxacin—Haemoglobin—Doxorubicin—kidney cancer	0.000102	0.000156	CcSEcCtD
Moxifloxacin—Headache—Gemcitabine—kidney cancer	0.000102	0.000156	CcSEcCtD
Moxifloxacin—Nausea—Vincristine—kidney cancer	0.000102	0.000156	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—kidney cancer	0.000102	0.00472	CbGpPWpGaD
Moxifloxacin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000102	0.000156	CcSEcCtD
Moxifloxacin—Rhinitis—Doxorubicin—kidney cancer	0.000101	0.000155	CcSEcCtD
Moxifloxacin—Hepatitis—Doxorubicin—kidney cancer	0.000101	0.000155	CcSEcCtD
Moxifloxacin—Haemorrhage—Doxorubicin—kidney cancer	0.000101	0.000155	CcSEcCtD
Moxifloxacin—Insomnia—Capecitabine—kidney cancer	0.000101	0.000154	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Doxorubicin—kidney cancer	0.000101	0.000154	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000101	0.00467	CbGpPWpGaD
Moxifloxacin—Pharyngitis—Doxorubicin—kidney cancer	0.0001	0.000154	CcSEcCtD
Moxifloxacin—Paraesthesia—Capecitabine—kidney cancer	0.0001	0.000153	CcSEcCtD
Moxifloxacin—Hypersensitivity—Paclitaxel—kidney cancer	0.0001	0.000153	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Doxorubicin—kidney cancer	0.0001	0.000153	CcSEcCtD
Moxifloxacin—Oedema peripheral—Doxorubicin—kidney cancer	9.97e-05	0.000153	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Doxorubicin—kidney cancer	9.95e-05	0.000152	CcSEcCtD
Moxifloxacin—Dyspnoea—Capecitabine—kidney cancer	9.95e-05	0.000152	CcSEcCtD
Moxifloxacin—Urethral disorder—Doxorubicin—kidney cancer	9.92e-05	0.000152	CcSEcCtD
Moxifloxacin—Dyspepsia—Capecitabine—kidney cancer	9.82e-05	0.00015	CcSEcCtD
Moxifloxacin—Visual impairment—Doxorubicin—kidney cancer	9.75e-05	0.000149	CcSEcCtD
Moxifloxacin—Asthenia—Paclitaxel—kidney cancer	9.75e-05	0.000149	CcSEcCtD
Moxifloxacin—Decreased appetite—Capecitabine—kidney cancer	9.7e-05	0.000148	CcSEcCtD
Moxifloxacin—Nausea—Gemcitabine—kidney cancer	9.64e-05	0.000148	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Capecitabine—kidney cancer	9.63e-05	0.000147	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—kidney cancer	9.62e-05	0.00447	CbGpPWpGaD
Moxifloxacin—Fatigue—Capecitabine—kidney cancer	9.62e-05	0.000147	CcSEcCtD
Moxifloxacin—Pruritus—Paclitaxel—kidney cancer	9.62e-05	0.000147	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	9.6e-05	0.00446	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	9.58e-05	0.00445	CbGpPWpGaD
Moxifloxacin—Erythema multiforme—Doxorubicin—kidney cancer	9.57e-05	0.000146	CcSEcCtD
Moxifloxacin—Constipation—Capecitabine—kidney cancer	9.54e-05	0.000146	CcSEcCtD
Moxifloxacin—Pain—Capecitabine—kidney cancer	9.54e-05	0.000146	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	9.51e-05	0.00441	CbGpPWpGaD
Moxifloxacin—Eye disorder—Doxorubicin—kidney cancer	9.46e-05	0.000145	CcSEcCtD
Moxifloxacin—Tinnitus—Doxorubicin—kidney cancer	9.44e-05	0.000144	CcSEcCtD
Moxifloxacin—Cardiac disorder—Doxorubicin—kidney cancer	9.39e-05	0.000144	CcSEcCtD
Moxifloxacin—Diarrhoea—Paclitaxel—kidney cancer	9.3e-05	0.000142	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	9.27e-05	0.0043	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—JUN—kidney cancer	9.2e-05	0.00427	CbGpPWpGaD
Moxifloxacin—Feeling abnormal—Capecitabine—kidney cancer	9.19e-05	0.000141	CcSEcCtD
Moxifloxacin—Angiopathy—Doxorubicin—kidney cancer	9.18e-05	0.000141	CcSEcCtD
Moxifloxacin—Immune system disorder—Doxorubicin—kidney cancer	9.14e-05	0.00014	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Capecitabine—kidney cancer	9.12e-05	0.00014	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Doxorubicin—kidney cancer	9.12e-05	0.00014	CcSEcCtD
Moxifloxacin—Chills—Doxorubicin—kidney cancer	9.08e-05	0.000139	CcSEcCtD
Moxifloxacin—Arrhythmia—Doxorubicin—kidney cancer	9.04e-05	0.000138	CcSEcCtD
Moxifloxacin—Dizziness—Paclitaxel—kidney cancer	8.99e-05	0.000138	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—PTEN—kidney cancer	8.9e-05	0.00413	CbGpPWpGaD
Moxifloxacin—Mental disorder—Doxorubicin—kidney cancer	8.87e-05	0.000136	CcSEcCtD
Moxifloxacin—Urticaria—Capecitabine—kidney cancer	8.86e-05	0.000136	CcSEcCtD
Moxifloxacin—Body temperature increased—Capecitabine—kidney cancer	8.82e-05	0.000135	CcSEcCtD
Moxifloxacin—Abdominal pain—Capecitabine—kidney cancer	8.82e-05	0.000135	CcSEcCtD
Moxifloxacin—Malnutrition—Doxorubicin—kidney cancer	8.81e-05	0.000135	CcSEcCtD
Moxifloxacin—Erythema—Doxorubicin—kidney cancer	8.81e-05	0.000135	CcSEcCtD
Moxifloxacin—Flatulence—Doxorubicin—kidney cancer	8.68e-05	0.000133	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—BRCA2—kidney cancer	8.68e-05	0.00403	CbGpPWpGaD
Moxifloxacin—Tension—Doxorubicin—kidney cancer	8.65e-05	0.000132	CcSEcCtD
Moxifloxacin—Vomiting—Paclitaxel—kidney cancer	8.64e-05	0.000132	CcSEcCtD
Moxifloxacin—Dysgeusia—Doxorubicin—kidney cancer	8.63e-05	0.000132	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2B—kidney cancer	8.6e-05	0.00399	CbGpPWpGaD
Moxifloxacin—Rash—Paclitaxel—kidney cancer	8.57e-05	0.000131	CcSEcCtD
Moxifloxacin—Dermatitis—Paclitaxel—kidney cancer	8.56e-05	0.000131	CcSEcCtD
Moxifloxacin—Nervousness—Doxorubicin—kidney cancer	8.56e-05	0.000131	CcSEcCtD
Moxifloxacin—Back pain—Doxorubicin—kidney cancer	8.52e-05	0.00013	CcSEcCtD
Moxifloxacin—Headache—Paclitaxel—kidney cancer	8.52e-05	0.00013	CcSEcCtD
Moxifloxacin—Muscle spasms—Doxorubicin—kidney cancer	8.47e-05	0.00013	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	8.37e-05	0.00389	CbGpPWpGaD
Moxifloxacin—Vision blurred—Doxorubicin—kidney cancer	8.3e-05	0.000127	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—kidney cancer	8.3e-05	0.00385	CbGpPWpGaD
Moxifloxacin—Hypersensitivity—Capecitabine—kidney cancer	8.22e-05	0.000126	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Doxorubicin—kidney cancer	8.18e-05	0.000125	CcSEcCtD
Moxifloxacin—Anaemia—Doxorubicin—kidney cancer	8.14e-05	0.000125	CcSEcCtD
Moxifloxacin—Agitation—Doxorubicin—kidney cancer	8.1e-05	0.000124	CcSEcCtD
Moxifloxacin—Nausea—Paclitaxel—kidney cancer	8.07e-05	0.000124	CcSEcCtD
Moxifloxacin—Asthenia—Capecitabine—kidney cancer	8e-05	0.000122	CcSEcCtD
Moxifloxacin—Malaise—Doxorubicin—kidney cancer	7.95e-05	0.000122	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.92e-05	0.00368	CbGpPWpGaD
Moxifloxacin—Vertigo—Doxorubicin—kidney cancer	7.92e-05	0.000121	CcSEcCtD
Moxifloxacin—Syncope—Doxorubicin—kidney cancer	7.9e-05	0.000121	CcSEcCtD
Moxifloxacin—Pruritus—Capecitabine—kidney cancer	7.89e-05	0.000121	CcSEcCtD
Moxifloxacin—Leukopenia—Doxorubicin—kidney cancer	7.89e-05	0.000121	CcSEcCtD
Moxifloxacin—Palpitations—Doxorubicin—kidney cancer	7.79e-05	0.000119	CcSEcCtD
Moxifloxacin—Loss of consciousness—Doxorubicin—kidney cancer	7.74e-05	0.000119	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.7e-05	0.00358	CbGpPWpGaD
Moxifloxacin—Cough—Doxorubicin—kidney cancer	7.69e-05	0.000118	CcSEcCtD
Moxifloxacin—Convulsion—Doxorubicin—kidney cancer	7.63e-05	0.000117	CcSEcCtD
Moxifloxacin—Diarrhoea—Capecitabine—kidney cancer	7.63e-05	0.000117	CcSEcCtD
Moxifloxacin—Hypertension—Doxorubicin—kidney cancer	7.61e-05	0.000116	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.53e-05	0.0035	CbGpPWpGaD
Moxifloxacin—Myalgia—Doxorubicin—kidney cancer	7.5e-05	0.000115	CcSEcCtD
Moxifloxacin—Chest pain—Doxorubicin—kidney cancer	7.5e-05	0.000115	CcSEcCtD
Moxifloxacin—Arthralgia—Doxorubicin—kidney cancer	7.5e-05	0.000115	CcSEcCtD
Moxifloxacin—Anxiety—Doxorubicin—kidney cancer	7.48e-05	0.000114	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.45e-05	0.000114	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—BIRC5—kidney cancer	7.42e-05	0.00345	CbGpPWpGaD
Moxifloxacin—Discomfort—Doxorubicin—kidney cancer	7.41e-05	0.000113	CcSEcCtD
Moxifloxacin—Dizziness—Capecitabine—kidney cancer	7.38e-05	0.000113	CcSEcCtD
Moxifloxacin—Dry mouth—Doxorubicin—kidney cancer	7.34e-05	0.000112	CcSEcCtD
Moxifloxacin—Confusional state—Doxorubicin—kidney cancer	7.25e-05	0.000111	CcSEcCtD
Moxifloxacin—Oedema—Doxorubicin—kidney cancer	7.19e-05	0.00011	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Doxorubicin—kidney cancer	7.19e-05	0.00011	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.12e-05	0.0033	CbGpPWpGaD
Moxifloxacin—Vomiting—Capecitabine—kidney cancer	7.09e-05	0.000109	CcSEcCtD
Moxifloxacin—Shock—Doxorubicin—kidney cancer	7.07e-05	0.000108	CcSEcCtD
Moxifloxacin—Nervous system disorder—Doxorubicin—kidney cancer	7.05e-05	0.000108	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Doxorubicin—kidney cancer	7.04e-05	0.000108	CcSEcCtD
Moxifloxacin—Rash—Capecitabine—kidney cancer	7.03e-05	0.000108	CcSEcCtD
Moxifloxacin—Dermatitis—Capecitabine—kidney cancer	7.03e-05	0.000108	CcSEcCtD
Moxifloxacin—Tachycardia—Doxorubicin—kidney cancer	7.02e-05	0.000107	CcSEcCtD
Moxifloxacin—Headache—Capecitabine—kidney cancer	6.99e-05	0.000107	CcSEcCtD
Moxifloxacin—Skin disorder—Doxorubicin—kidney cancer	6.98e-05	0.000107	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Doxorubicin—kidney cancer	6.95e-05	0.000106	CcSEcCtD
Moxifloxacin—Anorexia—Doxorubicin—kidney cancer	6.85e-05	0.000105	CcSEcCtD
Moxifloxacin—Hypotension—Doxorubicin—kidney cancer	6.72e-05	0.000103	CcSEcCtD
Moxifloxacin—Nausea—Capecitabine—kidney cancer	6.63e-05	0.000101	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.55e-05	0.0001	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.54e-05	0.00304	CbGpPWpGaD
Moxifloxacin—Insomnia—Doxorubicin—kidney cancer	6.5e-05	9.95e-05	CcSEcCtD
Moxifloxacin—Paraesthesia—Doxorubicin—kidney cancer	6.46e-05	9.88e-05	CcSEcCtD
Moxifloxacin—Dyspnoea—Doxorubicin—kidney cancer	6.41e-05	9.81e-05	CcSEcCtD
Moxifloxacin—Somnolence—Doxorubicin—kidney cancer	6.39e-05	9.78e-05	CcSEcCtD
Moxifloxacin—Dyspepsia—Doxorubicin—kidney cancer	6.33e-05	9.69e-05	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.32e-05	0.00294	CbGpPWpGaD
Moxifloxacin—Decreased appetite—Doxorubicin—kidney cancer	6.25e-05	9.57e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.21e-05	9.5e-05	CcSEcCtD
Moxifloxacin—Fatigue—Doxorubicin—kidney cancer	6.2e-05	9.49e-05	CcSEcCtD
Moxifloxacin—Constipation—Doxorubicin—kidney cancer	6.15e-05	9.41e-05	CcSEcCtD
Moxifloxacin—Pain—Doxorubicin—kidney cancer	6.15e-05	9.41e-05	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—TP53—kidney cancer	6.07e-05	0.00282	CbGpPWpGaD
Moxifloxacin—Feeling abnormal—Doxorubicin—kidney cancer	5.93e-05	9.07e-05	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Doxorubicin—kidney cancer	5.88e-05	9e-05	CcSEcCtD
Moxifloxacin—Urticaria—Doxorubicin—kidney cancer	5.71e-05	8.74e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Doxorubicin—kidney cancer	5.68e-05	8.7e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Doxorubicin—kidney cancer	5.68e-05	8.7e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	5.5e-05	0.00255	CbGpPWpGaD
Moxifloxacin—Hypersensitivity—Doxorubicin—kidney cancer	5.3e-05	8.11e-05	CcSEcCtD
Moxifloxacin—Asthenia—Doxorubicin—kidney cancer	5.16e-05	7.9e-05	CcSEcCtD
Moxifloxacin—Pruritus—Doxorubicin—kidney cancer	5.09e-05	7.79e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Doxorubicin—kidney cancer	4.92e-05	7.53e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2A—kidney cancer	4.92e-05	0.00228	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	4.87e-05	0.00226	CbGpPWpGaD
Moxifloxacin—Dizziness—Doxorubicin—kidney cancer	4.76e-05	7.28e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—kidney cancer	4.65e-05	0.00216	CbGpPWpGaD
Moxifloxacin—Vomiting—Doxorubicin—kidney cancer	4.57e-05	7e-05	CcSEcCtD
Moxifloxacin—Rash—Doxorubicin—kidney cancer	4.53e-05	6.94e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Doxorubicin—kidney cancer	4.53e-05	6.93e-05	CcSEcCtD
Moxifloxacin—Headache—Doxorubicin—kidney cancer	4.5e-05	6.89e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1B—kidney cancer	4.36e-05	0.00202	CbGpPWpGaD
Moxifloxacin—Nausea—Doxorubicin—kidney cancer	4.27e-05	6.54e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CCND1—kidney cancer	4.16e-05	0.00193	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—kidney cancer	3.83e-05	0.00178	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MYC—kidney cancer	3.73e-05	0.00173	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—kidney cancer	3.65e-05	0.00169	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MAPK3—kidney cancer	3.43e-05	0.00159	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MYC—kidney cancer	3.33e-05	0.00155	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MAPK1—kidney cancer	3.26e-05	0.00151	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TP53—kidney cancer	2.74e-05	0.00127	CbGpPWpGaD
